{"id":25010,"date":"2024-12-27T21:55:05","date_gmt":"2024-12-27T21:55:05","guid":{"rendered":"https:\/\/allonlinebanglanewspapers.com\/news\/crbu-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-caribou-biosciences-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/"},"modified":"2024-12-27T21:55:05","modified_gmt":"2024-12-27T21:55:05","slug":"crbu-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-caribou-biosciences-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit","status":"publish","type":"post","link":"https:\/\/allonlinebanglanewspapers.com\/news\/crbu-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-caribou-biosciences-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/","title":{"rendered":"CRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Caribou Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"},"content":{"rendered":"
\n

NEW YORK, Dec. 27, 2024 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Caribou Biosciences, Inc. (\u201cCaribou\u201d or \u201cthe Company\u201d) (NASDAQ: CRBU) and certain of its officers.<\/p>\n

Class Definition<\/strong><\/p>\n

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Caribou securities between July 14, 2023 and July 16, 2024, both dates inclusive (the \u201cClass Period\u201d). Such investors are encouraged to join this case by visiting the firm\u2019s site: bgandg.com\/CRBU.<\/u><\/a><\/p>\n

Case Details<\/strong><\/p>\n

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, the Complaint alleges that Defendants made false and\/or misleading statements and\/or failed to disclose that: (1) they had overstated CB-010’s safety, efficacy, and durability relative to approved autologous CAR-T cell therapies in treating patients with r\/r B-NHL and\/or LBCL, as well as CB-010’s overall clinical results and commercial prospects; (2) Caribou was at significant risk of having insufficient cash, liquidity, and\/or other capital to fund its current business operations, including preclinical research activities associated with the allogeneic CAR-NK platform; (3) all the foregoing was likely to have a significant negative impact on Caribou’s business and operations; and (4) as a result, Defendants’ public statements were materially false and misleading at all relevant times.<\/p>\n

What’s Next?<\/strong><\/p>\n

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm\u2019s site: bgandg.com\/CRBU.<\/u><\/a> or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660<\/u>. If you suffered a loss in Caribou you have until February 24, 2025, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff.<\/p>\n

There is No Cost to You<\/strong><\/p>\n

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys\u2019 fees, usually a percentage of the total recovery, only if we are successful.<\/p>\n

Why Bronstein, Gewirtz & Grossman<\/strong><\/p>\n

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.<\/p>\n

Follow us for updates on LinkedIn<\/u><\/a>, X<\/u><\/a>, Facebook<\/u><\/a>, or Instagram<\/u><\/a>.<\/p>\n

Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n

Contact<\/strong><\/p>\n

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660<\/u> | info@bgandg.com<\/u><\/a><\/p>\n

\n <\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, Dec. 27, 2024 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Caribou Biosciences, Inc. (\u201cCaribou\u201d or \u201cthe Company\u201d) (NASDAQ: CRBU) and certain of its officers. Class Definition This lawsuit seeks to recover damages against […]<\/p>\n","protected":false},"author":2,"featured_media":25011,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/a0da9a10-1592-437a-9c10-d30eeb243cb7","fifu_image_alt":"","footnotes":""},"categories":[11],"tags":[],"class_list":["post-25010","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t